Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T22608
(Former ID: TTDI01843)
|
|||||
Target Name |
TNF alpha production (TNFA produ)
|
|||||
Synonyms |
Tumor necrosis factor alpha production
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Chronic arterial occlusive disease [ICD-11: BD4Z] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | SH-529 | Drug Info | Phase 2 | Peripheral vascular disease | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | SH-529 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Particulate beta-glucan induces TNF-alpha production in wound macrophages via a redox-sensitive NF- beta-dependent pathway. Wound Repair Regen. 2011 May-Jun;19(3):411-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.